Clinical Trial Update: SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Yale University-led study uses SV2A and TSPO PET imaging to investigate mechanisms of HIV neuropathogenesis in individuals on antiretroviral therapy. The Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Encephalitis
• Hiv-associated Dementia
• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Yale University | Conditions: HIV Associated Neurocognitive Disorder, HIV Dementia | Phase 1, Phase 2 | Status: RECRUITING